Scinai Immunotherapeutics Battles Nasdaq Delisting
Scinai Immunotherapeutics Plans 1-for-10 Reverse Stock Split to Avoid Possible Delisting
Scinai Immunotherapeutics (SCNI) said Monday its board has approved a 1-for-10 reverse split of its American depository shares to take effect possibly on May 21 in a bid to lift its share price above
Express News | Scinai Immunotherapeutics Announces Receipt Of Nasdaq Delisting Notification And Appeal
Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal
The Board has Approved a Ratio Change of the ADSs to Non-traded Ordinary Shares (equivalent to a reverse split) Designed to Regain Compliance JERUSALEM, May 6, 2024 /PRNewswire/ -- Scinai Immunothera
Scinai Immunotherapeutics Advances NanoAb Pipeline
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersEliem Therapeutics (NASDAQ:ELYM) stock moved upwards by 51.6% to $4.05 during Thursday's pre-market session. The market value of their outstanding shares is at $112.2 million. Rallybio (NASDAQ:
12 Health Care Stocks Moving In Monday's After-Market Session
GainersKineta (NASDAQ:KA) shares increased by 24.3% to $0.67 during Monday's after-market session. The market value of their outstanding shares is at $7.3 million. Moleculin Biotech (NASDAQ:MBRX) stoc
Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and CGMP Manufacturing Services
JERUSALEM, April 8, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) today announced that Ayana Pharma Ltd. signed a five-year Master Service Agreement (MSA) with the Company's CDMO
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersNuCana (NASDAQ:NCNA) stock rose 157.2% to $0.99 during Tuesday's after-market session. The market value of their outstanding shares is at $52.2 million. Qilian Intl Hldg Gr (NASDAQ:QLI) stock m
Scinai Leadership to Attend BIO-Europe Spring 2024
Scinai to Showcase Its CGMP Biologics CDMO and Innovative NanoAb Pipeline at MIXiii 2024
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological...
Press Release: Scinai Welcomes Liat Halpert as Head of Business Development and Sales
Scinai Welcomes Liat Halpert as Head of Business Development and Sales PR Newswire JERUSALEM, Feb. 13, 2024 JERUSALEM, Feb. 13, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersSocietal CDMO (NASDAQ:SCTL) shares moved upwards by 23.4% to $0.57 during Wednesday's pre-market session. The market value of their outstanding shares is at $59.7 million. Apollomics (NASDAQ:AP
12 Health Care Stocks Moving In Friday's After-Market Session
GainersInVivo Therapeutics Hldg (NASDAQ:NVIV) shares moved upwards by 30.1% to $0.41 during Friday's after-market session. The market value of their outstanding shares is at $1.2 million. Scinai Immun
Scinai Immunotherapeutics Files to Sell 5.36M ADS for Holders
Scinai Immunotherapeutics Congratulates Its Co-Lead Scientific Research Collaborator Dirk Görlich on Louis-Jeantet Prize
JERUSALEM, Jan. 25, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on development of inflammation and immunology (I&I) biological products, co
Scinai Immunotherapeutics CEO Issues Letter to Shareholders
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on development of inflammation and immunology (I&I) biological...
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersChina SXT Pharmaceuticals (NASDAQ:SXTC) shares increased by 185.1% to $5.73 during Monday's pre-market session. The company's market cap stands at $3.2 million. cbdMD (AMEX:YCBD) stock moved up
Express News | Scinai Immunotherapeutics Announces Exercise Of Outstanding Warrants For $1.69M In Gross Proceeds
Scinai (NASDAQ: SCNI) to Host Analyst and Investor Webinar on January 9
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), a biopharmaceutical company focused both on development of inflammation and immunology (I&I)...
No Data